| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2022―Jan―31 |
Navigating Pricing Models for COVID-19 Innovations |
Jacquelyn W Chou |
| 2 |
[GO] |
2022―Jan―31 |
COVID-19 Pandemic Vindicates the ISPOR Value Flower |
Jason Shafrin, Kathy Lang, Ross Maclean |
| 3 |
[GO] |
2022―Jan―31 |
Does COVID-19 Threaten the Progress Pharmaceuticals Have Made in Reducing Cancer Mortality Over the Last 20 Years? |
Joanna P MacEwan, Jason Shafrin, Farzad Ali |
| 4 |
[GO] |
2022―Jan―31 |
We Have Vaccines, Now What? How to Ensure Continued COVID-19 Vaccine Discovery and Expedite Access |
Jason Shafrin, Marlon Graf, Rifat Tuly, Christoph Glaetzer, Dipl Kfm, Stacey Hickson, Joseph Mattingly II |
| 5 |
[GO] |
2022―Jan―31 |
How COVID-19 Will Change the Patient Journey, Reimbursement, and Care Delivery |
Richard G Stefanacci |
| 6 |
[GO] |
2022―Jan―31 |
Cancer Care in 2021 and Beyond: Catalytic Trends, Entrants, and Developments to Optimize Care During and Post Pandemic |
Elizabeth Oyekan |
| 7 |
[GO] |
2022―Jan―31 |
COVID-19 and Diabetes: Strategies to Catch Up |
Cynthia Miller |
